This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Findcure.org, Plurogen Therapeutics, Inc., Other. Active years: 2015-2019.
Location History:
- Annapolis, MD (US) (2015 - 2017)
- Norristown, PA (US) (2019)
Company Filing History:
Years Active: 2015-2019
Title: The Innovative Mind of Neal Koller
Introduction
Neal Koller, an accomplished inventor based in Annapolis, Maryland, has made significant contributions to the field of medical innovations. With three patents to his name, Koller has demonstrated a commitment to advancing technologies that address pressing health issues.
Latest Patents
Neal Koller’s latest patents reflect his focus on treating microbial infections and enhancing healing processes. One notable patent involves "Compositions and methods of treating microbes," which presents various compositions that target microbial infections, particularly those forming biofilms. The invention also highlights the use of surface active agents that can be anionic, cationic, or non-ionic, providing a versatile approach to microbial treatment. Another significant patent is for a "Homeopathic drug composition and methods of use thereof," which includes homeopathic preparations aimed at alleviating disease symptoms through innovative delivery systems.
Career Highlights
Throughout his career, Koller has worked with notable companies that support his innovative endeavors, including Plurogen Therapeutics, Inc. His work in these environments has allowed him to collaborate with other experts and contribute to the advancement of medical treatments.
Collaborations
Neal Koller's collaborative spirit is evident in his professional relationships with colleagues such as George Rodeheaver and John Bistline, Jr. These partnerships have likely enriched his work and fostered an environment of creativity and innovation.
Conclusion
Neal Koller stands as a testament to the power of innovation in medicine. His contributions through various patents and collaborations continue to pave the way for new treatments and technologies, reflecting the ongoing importance of inventors in addressing critical health challenges.